#sun-pharmaceutical-industries
As a headsup for anyone on Vyvanse, you should go check your lot numbers.

www.health.com/adhd-medicat...
FDA Announces Nationwide Recall of ADHD Medication—Check Your Cabinets Now
Sun Pharmaceutical Industries has recalled several lots lisdexamfetamine dimesylate capsules, a generic form of Vyvanse, after testing found they failed to dissolve properly.
www.health.com
November 5, 2025 at 3:18 PM
Pfizer Inc. said in a new federal lawsuit that Sun Pharmaceutical Industries Ltd.'s proposed copies of cancer drug Lorbrena infringe four patents for the lung cancer drug.
Pfizer Sues Sun Pharmaceutical to Block Copies of Cancer Drug
Pfizer Inc. said in a new federal lawsuit that Sun Pharmaceutical Industries Ltd.'s proposed copies of cancer drug Lorbrena infringe four patents for the lung cancer drug.
bit.ly
October 5, 2026 at 8:00 AM
"Sun Pharmaceutical Industries has recalled several lots of lisdexamfetamine dimesylate capsules, a generic form of Vyvanse.

The FDA classified the recall as Class II, indicating a low risk of serious health consequences but potential temporary or reversible effects."
November 5, 2025 at 7:19 PM
Sun Pharmaceutical Industries Limited (India) — via Sun Pharma ANZ Pty Ltd
* Gonadron (testosterone undecanoate)
* Testosterone RBX (testosterone undecanoate)
* Testosterone Sun (testosterone undecanoate)
April 25, 2025 at 9:34 AM
2) This particular alert is for a generic, Sun Pharmaceutical Industries lisdexamfetamine dimesylate. If you are on Takeda Vyvanse, the name brand, you don't have to worry about it. You, again, don't have to worry if you're in Australia; Sun lisdexamfetamine is not on the ARTG, so you're not on it.
November 6, 2025 at 6:37 AM
The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies
Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms
The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and Sun Pharmaceutical Industries Ltd.
bloom.bg
August 31, 2026 at 7:45 PM
Pfizer Inc. said in a new federal lawsuit that Sun Pharmaceutical Industries Ltd.'s proposed copies of cancer drug Lorbrena infringe four patents for the lung cancer drug.
Pfizer Sues Sun Pharmaceutical to Block Copies of Cancer Drug
Pfizer Inc. said in a new federal lawsuit that Sun Pharmaceutical Industries Ltd.'s proposed copies of cancer drug Lorbrena infringe four patents for the lung cancer drug.
bit.ly
October 2, 2026 at 6:20 PM
Sun Pharma cleared to sell generic Wegovy, intensifies India's obesity‑drug race reut.rs/4bMEJoU
Sun Pharma cleared to sell generic Wegovy, intensifies India's obesity‑drug race
Sun Pharmaceutical Industries , India's top drugmaker by revenue, said on Friday it has received a regulatory nod to manufacture and sell semaglutide, the generic version of blockbuster weight-loss drug Wegovy, in the populous nation.
reut.rs
January 23, 2026 at 6:45 AM
Sun Pharmaceutical Industries has recalled several lots of lisdexamfetamine dimesylate capsules, a generic form of Vyvanse.

if you get a generic form of vyvanse check your rx label to see if it was manufactured by sun pharmaceuticals. if so follow instructions in article through original quote post
November 6, 2025 at 1:36 AM
Indian generic medicines giant Sun Pharmaceutical Industries is buying the women’s health company Organon in a deal worth $11.75 billion.

#chemsky 🧪
Sun Pharma to buy Organon for more than $11 billion
Biggest deal of the year so far shows that the recent surge in M&A is not limited to US companies
cen.acs.org
April 28, 2026 at 9:05 PM
India's Sun Pharma wins South Africa approval to launch generic Ozempic reut.rs/4aTrtxE
India's Sun Pharma wins South Africa approval to launch generic Ozempic
India's Sun Pharmaceutical Industries has received approval from South Africa's health regulator to manufacture and ​sell a generic version of semaglutide, the active ingredient ‌in Novo Nordisk's top-selling diabetes and obesity drugs.
reut.rs
July 15, 2026 at 4:40 PM
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
To fuel its global ambitions, Sun Pharmaceutical Industries plans to acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.
cnb.cx
April 27, 2026 at 2:16 AM
India's Sun Pharma to buy Organon in $11.75 billion all-cash deal reut.rs/42uBRan
India's Sun Pharma to buy Organon in $11.75 billion all-cash deal
India's ​Sun Pharmaceutical Industries will ‌buy Organon & Co in an all‑cash deal, ​valuing the U.S. ​drugmaker at about $11.75 billion ⁠including debt, the companies ​said on Sunday.
reut.rs
April 27, 2026 at 12:30 AM
US FDA deems Sun Pharma's Halol plant not compliant with its manufacturing rules reut.rs/4gk3idh
US FDA deems Sun Pharma's Halol plant not compliant with its manufacturing rules
Indian drugmaker Sun Pharmaceutical Industries said on Tuesday the U.S. Food and Drug Administration had determined that its Halol plant in the western state of Gujarat was not compliant with the regulator's manufacturing rules.
reut.rs
September 9, 2025 at 4:05 PM
Recall on generic Vyvanse (lisdexamphetamine)

see link for the dosage, manufacturer & dates impacted by the recall

If impacted, your pharmacy ought to be reaching out but I'm sure you've waited in line at the pharmacy long enough to wanna check out the link & just make sure, y'know, just in case
FDA Announces Nationwide Recall of ADHD Medication—Check Your Cabinets Now
Sun Pharmaceutical Industries has recalled several lots lisdexamfetamine dimesylate capsules, a generic form of Vyvanse, after testing found they failed to dissolve properly.
www.health.com
November 5, 2025 at 2:35 PM
India's Sun Pharmaceuticals announces $12 billion acquisition of debt-ridden New Jersey-based Organon, a Merck spinoff focused on women's healthcare and biosimilars. m.economictimes.com/markets/s...
Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisition
Sun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in women's health. This strategic move aims to bolster Sun Pharma's innovative medicines business and establish it as a top-tier player in biosimilars and women's health globally.
m.economictimes.com
April 27, 2026 at 11:35 AM
India's Sun Pharma posts profit beat on specialty drug demand, shares slide on cost pressures reut.rs/4uq7MFg
India's Sun Pharma posts profit beat on specialty drug demand, shares slide on cost pressures
Sun Pharmaceutical Industries' fourth-quarter profit edged ​past estimates, helped by robust demand for its specialty ‌drugs, although increasing cost pressures squeezed margins and sent shares lower on Friday.
reut.rs
May 22, 2026 at 3:05 PM